Janis M Taube Selected Research

Janis M Taube Research Topics

Disease

79	Neoplasms (Cancer) 03/2024 - 08/2007
34	Melanoma (Melanoma, Malignant) 03/2024 - 07/2010
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 07/2010
10	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 07/2010
9	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 07/2010
7	Disease Progression 05/2024 - 04/2014
7	Merkel Cell Carcinoma 12/2021 - 07/2013
7	Carcinoma (Carcinomatosis) 05/2016 - 06/2007
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2023 - 01/2008
6	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2013
5	Lung Neoplasms (Lung Cancer) 05/2024 - 01/2017
5	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 07/2010
4	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2017
4	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2008
4	Body Weight (Weight, Body) 05/2018 - 06/2012
2	Inflammation (Inflammations) 03/2024 - 12/2017
2	Brain Neoplasms (Brain Tumor) 10/2023 - 03/2016
2	Glioblastoma (Glioblastoma Multiforme) 12/2018 - 01/2017
2	Hodgkin Disease (Hodgkin's Disease) 07/2017 - 11/2016
2	Basal Cell Carcinoma (Rodent Ulcer) 01/2017 - 04/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 11/2016 - 05/2016
2	Noninfiltrating Intraductal Carcinoma (DCIS) 03/2016 - 06/2013
2	Skin Diseases (Skin Disease) 08/2015 - 05/2010
1	Skin Neoplasms (Skin Cancer) 01/2024
1	Cardiomyopathies (Cardiomyopathy) 11/2023
1	Hypophysitis 11/2023
1	Pathologic Complete Response 10/2023
1	Uveal melanoma 10/2023
1	Necrosis 01/2023
1	Microsatellite Instability 11/2022
1	Lichen Planus (Lichen Ruber Planus) 08/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2022
1	Infections 01/2021
1	Human Influenza (Influenza) 01/2021

Drug/Important Bio-Agent (IBA)

24	Biomarkers (Surrogate Marker)IBA 10/2023 - 04/2009
21	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2013
15	NivolumabIBA 05/2024 - 01/2013
12	B7-H1 AntigenIBA 10/2023 - 09/2015
9	Proteins (Proteins, Gene)FDA Link 10/2023 - 08/2007
9	LigandsIBA 01/2022 - 06/2012
8	CytokinesIBA 04/2018 - 03/2012
7	pembrolizumabIBA 01/2021 - 06/2015
7	ParaffinIBA 08/2017 - 05/2010
6	Formaldehyde (Formol)FDA Link 08/2017 - 10/2012
5	AntibodiesIBA 01/2021 - 08/2015
5	Monoclonal AntibodiesIBA 01/2020 - 03/2016
4	Programmed Cell Death 1 ReceptorIBA 10/2023 - 01/2016
4	DNA (Deoxyribonucleic Acid)IBA 04/2014 - 01/2008
3	durvalumabIBA 11/2023 - 07/2017
3	PlatinumIBA 11/2023 - 05/2016
3	Estrogen ReceptorsIBA 11/2017 - 06/2013
3	Messenger RNA (mRNA)IBA 11/2016 - 12/2012
2	AntigensIBA 03/2024 - 03/2016
2	IpilimumabIBA 01/2024 - 11/2016
2	Prednisone (Sone)FDA LinkGeneric 01/2024 - 01/2020
2	cemiplimabIBA 11/2023 - 10/2022
2	Dihydrotachysterol (AT 10)IBA 01/2023 - 07/2010
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 11/2016
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 07/2017
2	olaparibIBA 01/2020 - 07/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2018 - 10/2011
2	Hematoxylin (Haematoxylon)IBA 01/2018 - 10/2011
2	Chimeric Antigen ReceptorsIBA 11/2017 - 11/2016
2	Epidermal Growth Factor (EGF)IBA 11/2017 - 03/2016
2	Transcription Factors (Transcription Factor)IBA 07/2017 - 01/2015
2	InterferonsIBA 07/2017 - 03/2012
2	Immunoglobulins (Immunoglobulin)IBA 01/2017 - 07/2015
2	Immunomodulating AgentsIBA 11/2016 - 10/2014
2	Progesterone Receptors (Progesterone Receptor)IBA 03/2016 - 06/2013
2	Neoplasm Antigens (Tumor Antigens)IBA 03/2016 - 03/2012
2	Interferon-gamma (Interferon, gamma)IBA 09/2015 - 07/2015
1	Dinoprostone (PGE2)FDA Link 03/2024
1	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 03/2024
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2024
1	prednylidene (Pred)IBA 01/2024
1	PotassiumIBA 11/2023
1	HLA-A Antigens (HLA-A)IBA 10/2023
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2023
1	Interleukin-2 (IL2)IBA 01/2022
1	HLA-DR Antigens (HLA-DR)IBA 12/2021
1	Interleukin-7 (Interleukin 7)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	theasinensin AIBA 01/2021
1	CarcinogensIBA 01/2021
1	liquid crystal polymerIBA 01/2021

Therapy/Procedure

48	Therapeutics 10/2023 - 07/2010
33	Immunotherapy 11/2023 - 01/2013
13	Drug Therapy (Chemotherapy) 05/2024 - 05/2016
8	Neoadjuvant Therapy 10/2023 - 05/2016
5	Aftercare (After-Treatment) 02/2023 - 04/2014
2	Intravenous Infusions 01/2023 - 07/2010
2	Adjuvant Chemotherapy 01/2022 - 06/2007
2	Radiotherapy 01/2020 - 03/2016
2	Precision Medicine 01/2018 - 11/2016
2	Castration 10/2014 - 06/2012
1	Nephrectomy 01/2024
1	Surgical Amputation (Amputations) 11/2023
1	Oncolytic Virotherapy 10/2023
1	Injections 10/2023
1	Salvage Therapy 01/2021